Stelios Papadopoulos

(Dr. Stelios Papadopoulos Ph.D.)

Currently holds positions in Regulus Therapeutics Inc, Biogen Inc and Exelixis Inc

Positions
Position Company Period
Independent Chairman of the Board Regulus Therapeutics Inc June 11, 2013 -
Independent Chairman of the Board Biogen Inc June 1, 2014 -
Independent Chairman of the Board, Co-Founder Exelixis Inc Jan. 1, 1998 -
Independent Director Biogen Inc July 1, 2008 - June 1, 2014
Independent Director Regulus Therapeutics Inc Jan. 2, 2009 - June 11, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-02-24 2022-02-22
US Exelixis Inc (EXEL)
S Sale
84,515 -6.5%
19.56
1,653,113 USD 		84,515 -6.5% 19.56 1,653,113 USD
2021-05-13 2021-05-11
US Exelixis Inc (EXEL)
S Sale
5,473 -0.4%
25.01
136,880 USD 		5,473 -0.4% 25.01 136,880 USD
2021-05-13 2021-05-11
US Exelixis Inc (EXEL)
S Sale
5,075 -0.4%
25.00
126,875 USD 		5,075 -0.4% 25.00 126,875 USD
2021-05-13 2021-05-11
US Exelixis Inc (EXEL)
S Sale
10,222 -0.8%
24.95
255,039 USD 		10,222 -0.8% 24.95 255,039 USD
2020-05-08 2020-05-08
US Exelixis Inc (EXEL)
S Sale
45,000 -4.1%
25.84
1,162,800 USD 		45,000 -4.1% 25.84 1,162,800 USD
2019-05-08 2019-05-07
B Purchase
370,370 +45.2%
1.08
400,000 USD 		370,370 +45.2% 1.08 400,000 USD
2019-02-22 2019-02-21
US Exelixis Inc (EXEL)
S Sale
26,250 -2.5%
21.25
557,813 USD 		26,250 -2.5% 21.25 557,813 USD
2019-01-02 2018-12-28
B Purchase
50,000 +6.4%
1.09
54,570 USD 		50,000 +6.4% 1.09 54,570 USD
2018-12-28 2018-12-26
B Purchase
90,000 +13.5%
0.95
85,878 USD 		90,000 +13.5% 0.95 85,878 USD
2017-07-25 2017-07-25
B Purchase
1,000,000 +129.8%
0.91
910,000 USD 		1,000,000 +129.8% 0.91 910,000 USD
2017-03-23 2017-03-21
B Purchase
200,000 +99.7%
1.20
239,800 USD 		200,000 +99.7% 1.20 239,800 USD